In our previous study 6-8, we found that insulin resistance contributes to multidrug resistance in HCC cells via activation of the ER stress, suggesting that KSR2 may be involved in therapy resistance in insulin resistant HCC. The gene discussed is KSR2; the disease is hepatocellular carcinoma.